Carolinas Wealth Consulting’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Carolinas Wealth Consulting's AMGN Position: Q2 2025 in Review
Carolinas Wealth Consulting sold out of Amgen (AMGN) in Q2 2025, closing a stake of 277 shares — an estimated $86.2K sold.
Carolinas Wealth Consulting first reported a position in AMGN in Q2 2020 and held it in 20 quarters. The position peaked at $389K in Q1 2021. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.
- Carolinas Wealth Consulting reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
- Carolinas Wealth Consulting sold 277 Amgen shares in Q2 2025, an estimated $86.2K.
- Carolinas Wealth Consulting first reported a position in Amgen in Q2 2020 and held it in 20 quarters.
- Carolinas Wealth Consulting's Amgen position peaked at $389K in Q1 2021.
- 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.
Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.